Acquisitions & PartnershipsAutomationBioprintingPress Releases

regenHU and Wako Automation Collaborate to Promote 3D Bioprinting in Drug-discovery in the USA

Leading bioprinter manufacturer regenHU appointed Wako Automation as their official systems integrator for the USA. Recent advances in 3D-Bioprinting provide a valuable tool in the fabrication of biomimetic tissue constructs which can be applied at various stages of drug discovery research and development.


“The collaboration with regenHU will enable customers at the forefront of drug discovery to fully integrate regenHU 3D Bioprinters into advanced drug discovery systems” Robert Bukar, Director of Business Development at Wako Automation.

regenHU — a three-dimensional biotechnology company exploiting the potential of 3D bioprinting & cell-based therapies — is leading the development of biomedical products for regenerative medicine & drug discovery by combining efforts with Wako Automation, a San Diego based lab automation solutions provider, to integrate 3D Bioprinting solutions into automated drug discovery systems.

“The synergies of our expertise offer a unique value solution to leading pharma & biotech innovators allowing us to individualize the specific needs of each development”. Marc Thurner, CEO of regenHU.

Wako Automation is an experienced lab automation solution provider and leading distributor of Yokogawa’s CV8000 confocal high content screening system known for its high speed and flexibility. “Microscopy and additive manufacturing” are two key components of our customers’ drug development process.

Wako Automation and regenHU will demonstrate their technology at the SLAS Conference in San Diego next February 3-7.

Research 2020
Composites AM Market Opportunities

This 170-page study from 3dpbm Research provides an in-depth analysis of each major sub-segment in composites...

3D Printing Media Network

3D Printing Media Network is the editorial branch of 3D Printing Business Directory. It was set up to provide the latest industry news and opinions to a global audience of professionals.

Related Articles

Back to top button

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services



Join industry leaders and receive the latest insights on what really matters in AM!

This information will never be shared with 3rd parties

I’ve read and accept the privacy policy.*